PHARMAXIS LTD (PXS)

The company is a specialist pharmaceutical company committed to the research, development and commercialisation of human therapeutic products for chronic respiratory disorders.

On this page you will find:

Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
PXS	0.180	5.88%	0.180	0.185	0.175	0.195	0.175	3,602,909

PHARMAXIS LTD details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	PXS
Securities	ASX Code, Security Description ------------------------------ PXS, Ordinary Fully Paid
Official Listing Date	10 November, 2003
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.pharmaxis.com.au/
Registered Office Address	Unit 2, 20 Rodborough Road, FRENCHS FOREST, NSW, AUSTRALIA, 2086
Head Office Telephone	(02) 9454 7200
Head Office Fax	(02) 9451 3622
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Malcolm McComas (Chairman) Mr Gary Jonathan Phillips (CEO, Director) Dr Simon Hugh William Buckingham (Non Exec. Director) Mr Will Delaat (Independent Director) Dr John Villiger (Independent Director) Mr Richard van den Broek (Independent Director) Mr David McGarvey (CFO, Investor Relations)

Company Secretary	Mr David McGarvey
Principal Activities	The company is a specialist pharmaceutical company committed to the research, development and commercialisation of human therapeutic products for chronic respiratory disorders.

PHARMAXIS LTD announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
23/05/2013		Investor Conference Call - Results of Business Plan	1	PDF
22/05/2013		Pharmaxis Appoints Bronchitol Distributor for Poland	2	PDF
21/05/2013		Pharmaxis Agrees Key Cystic Fibrosis Trial Paramaters with F	2	PDF
20/05/2013		Ceasing to be a substantial holder	1	PDF
17/05/2013		Ceasing to be a substantial holder	1	PDF
14/05/2013		FDA Meeting, Business Review Announcement End of May	2	PDF
06/05/2013		Becoming a substantial holder	4	PDF
03/05/2013		Change of Director's Interest Notice	2	PDF
29/04/2013		Ceasing to be a substantial holder	2	PDF
24/04/2013		Investor presentation - B305	7	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
22 May 2013	0.170	-15%	0.255	0.170	19,636,913
21 May 2013	0.200	48.15%	0.210	0.122	14,832,833
20 May 2013	0.135	-3.57%	0.145	0.135	2,324,831
17 May 2013	0.140	-3.45%	0.150	0.140	1,700,188
16 May 2013	0.145	-3.33%	0.155	0.145	1,568,295

* Volume of shares shown represents only those shares traded on ASX.

PHARMAXIS LTD price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PXS. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PXS

Warrants & Structured Products

No warrants & Structured Products are available over the security PXS

ASX CFDs

No Contracts For Differences are available over the security PXS

MyASX: Login | Sign up